ArticleMolecular and clinical oncology2026
Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.
Wakako Inohana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.